Bio Techne Appoints Kim Kelderman As Chief Executive Officer

Oct 21, 2023•over 1 year ago

Position

President

Company

BIO-TECHNE

Kim Kelderman

MinneapolisBiotechnology Research

Description

MINNEAPOLIS, Oct. 19, 2023 /PRNewswire/ -- Bio-Techne Corporation today announced that its Board of Directors appointed Kim Kelderman as President and Chief Executive Officer effective February 1, 2024. Concurrent with his role as CEO, Mr

Company Information

Company

BIO-TECHNE

Location

Minneapolis, Minnesota, United States

About

Bio-Techne Corporation (NASDAQ: TECH) is a leading developer and manufacturer of high-quality purified proteins and reagent solutions - notably cytokines and growth factors, antibodies, immunoassays, biologically active small molecule compounds, tissue culture reagents, and cell and gene therapy workflow solutions including T-Cell activation technologies. Bio-Techne’s portfolio also includes protein analysis solutions, sold under the ProteinSimple brand name, that offer researchers efficient and streamlined options for automated Western blot and multiplexed ELISA workflow. These reagent and protein analysis solutions are sold to biomedical researchers, as well as clinical research laboratories, and constitute the Protein Sciences Segment.

Executive Insights

Based on hiring data

New executive impact window

87% of new executives make significant technology decisions within first 100 days

Budget influence

C-level executives control 73% of technology spending decisions

Transformation catalyst

65% of new senior hires launch digital transformation initiatives

Vendor review timeline

New executives typically review existing vendors within 6 months

Related People

Kim hidden

hidden

MATTHEW hidden